Share

October 02, 2012; 79 (14) Articles

Neurologic complications of influenza A(H1N1)pdm09

Surveillance in 6 pediatric hospitals

Gulam Khandaker, Yvonne Zurynski, Jim Buttery, Helen Marshall, Peter C. Richmond, Russell C. Dale, Jenny Royle, Michael Gold, Tom Snelling, Bruce Whitehead, Cheryl Jones, Leon Heron, Mary McCaskill, Kristine Macartney, Elizabeth J. Elliott, Robert Booy
First published September 19, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31826d5ea7
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
663

Share

Article Information

vol. 79 no. 14 1474-1481
DOI: 
https://doi.org/10.1212/WNL.0b013e31826d5ea7
PubMed: 
22993280
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 24, 2011
  • Accepted April 19, 2012
  • First Published September 19, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Gulam Khandaker, MPH,
    2. Yvonne Zurynski, PhD,
    3. Jim Buttery, FRACP,
    4. Helen Marshall, MD,
    5. Peter C. Richmond, FRACP,
    6. Russell C. Dale, PhD,
    7. Jenny Royle, MD,
    8. Michael Gold, MD,
    9. Tom Snelling, FRACP,
    10. Bruce Whitehead, MD,
    11. Cheryl Jones, PhD,
    12. Leon Heron, FRCPA,
    13. Mary McCaskill, FACEM,
    14. Kristine Macartney, MD,
    15. Elizabeth J. Elliott, MD and
    16. Robert Booy, MD
  1. Gulam Khandaker, MPH,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Doctoral student, Discipline of Pediatrics and Child Health, The University of Sydney

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Yvonne Zurynski, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council Australia (grant number 633028); Chief investigator B; 1 year 2009- 2010

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jim Buttery, FRACP,
    4. Scientific Advisory Boards:

    1. I have served on data safety monitoring boards for CSL, an Australian vaccine manufacturer of influenza vaccines. All payments are made to my institute to an educational fund.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I serve on Australian federal government committees and advisory groups which advise on medicines and vaccines. I am paid a per diem for this activity. The committees and groups are: Pharmaceutical Benefits Advisory Committee, Paediatric Medcines Advisory Committee, National Medicines Policy Committee.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Helen Marshall, MD,
    5. Scientific Advisory Boards:

    1. 1. GlaxoSmithKline scientific advisory board on meningococcal disease and vaccines and pertussis 2. Merck paediatric vaccines scientific advisory board 3. Novartis scientific advisory board on meningococcal vaccines

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1. Pfizer funded travel to present results of clinical trial of meningococcal vaccine

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. GlaxoSmithKline provided funding for pertussis study 2. Novartis vaccines provided funding for pertussis study 3. Sanofi-Pasteur provided funding for pertussis study

    Research Support, Government Entities:

    1. 1. NHMRC NHMRC Career Development Fellowship 1016272 2011 – 2014Marshall H (CIA) 2. NHMRC 2011 – 2013 NHMRC project grant No. 1011942. 2011 - 2013Marshall H (CIE) 3. ARC Linkage Project LP100200007. Investigator 2010-2012 4. NHMRC H1N1 Influenza 09 Grant No.626867. Marshall H (CIA)2009-2010 5. NHMRC project grant No. 570756. 2009 – 2011 Marshall H (CID). 2009- 2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Peter C. Richmond, FRACP,
    6. Scientific Advisory Boards:

    1. 1) CSL Ltd Scientific Advisory Board for new influenza vaccine

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) sanofi funded travel to speak at Influenza symposium at World Pediatric Infectious Disease Congress Nov 2011

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Received Institutional research funding for sponsored clinical trials from from CSL Ltd (2005-2010), sanofi (2008-present), Baxter (2009-11), GlaxoSmithKline (2009- 11), Pfizer (2009-present); Medimmune (2009-11) that do not relate to present work

    Research Support, Government Entities:

    1. 1.NHMRC funding as Chief Investigator on grant nos. 633028 (2009-10 - funded current work); 572548 (2009-11); 513836 (2008-10); 572590 (2009-11); 572689 (2009-11) 570576 (2009-12) 2.WA Health Dept. Funded as primary investigator (2007- present) 3. Australian Research Council Grant #0989464 Co- investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Russell C. Dale, PhD,
    7. Scientific Advisory Boards:

    1. Dr Dale is on the scentific advisory board for the Brisbane Children’s Hospital Medical research advisory committee

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. I am editor of the book ’Autoimmune and inflammatory disorders of the nervous system in children’ by MacKeith press, UK, 2009. I am expected to receive small monies from this.

    Employment, Commercial Entity:

    1. Chilean Paediatric Neurology association 2007, Oct. No company sponsorship. International paediatric MS research group, April 2009, Toronto, Canada. Sponsored only by MS research charities. I have received an honorarium from Biogen Idec for a talk on paediatric demyelination (Feb 2010)

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. We received a competitive grant from the American tourette syndrome association, Star Scientific foundation, NHMRC

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Brain Foundation research grant, research grant for demyelination work, October 2007 Pfizer Neuroscience award, research grant for encephalitis work, October 2008 University of Sydney postdoc fellowship, October 2007

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Jenny Royle, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Michael Gold, MD,
    9. Scientific Advisory Boards:

    1. Non profit entity. Therapeutic Goods Administration of the Commonwealth Government of Australia (Horvarth Expert Party of Experts) Honararium November 2011.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Commercial entity - Numico- Prevention of Atopy using Cows Milk Hydrolysate (PATCH) study - 2010 (2007-2009)

    Research Support, Government Entities:

    1. Australian Research Council. Principle Investigator. Can we and should we link data at national level. Vaccine safety surveillance. A case study. (2008-2010) National Health Medical Reaserch Council (NHMRC). Co- Investigator. LCPUFA supplementation in pregnancy and development of asthma. (2011-2014). Department of Health and Ageing - Commonwealth Government. Principle site Investigator. The Paediatric Active Event and Disease Surveillance (PAEDS) (Adelaide site) (2011-2013)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Tom Snelling, FRACP,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council, Project Grant; , Chief Investigator, 2008-2010.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Bruce Whitehead, MD,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Hunter Children’s Research Foundation (affiliated with Hunter Medical Research Institute)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Cheryl Jones, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Travel accomodation honoraria from World Society of Pediatric infectious Diseases for presentation at WSPID ASM 2012 in Melbourne, Vic Australia

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHMRC 570742, Defining the dynamics and function of dendritic cells after cutaneous HSV infection in vivo. Jones CA (CI-A), Weninger W / 3 yrs Role: Conceptualised and designed experiments., wrote grant. Will oversee bulk of research by postdoctoral fellow and PhD student. 2011-16 NHMRC CRE ID no. 1001021 Centre for Research Excellence in Critical Infections. Iredell, Sorell, Booy, Gilbert, Kerridge, Dwyer, Webb, Sintchenko, C Jones (CI- I), Bennet. 2009-11: NHMRC Project grant 571024. Mechanisms of disease in bacterial meningitis. Hunt N, Ball H, C. Jones (CI-C) 2008-10. Australian Research Council Discovery Grant.DP08777013 The effect of age on regulatory T cell control of innate and adaptive antiviral immune responses, Jones CA- CIA, Cunningham AC- CIB, Alexander SL- CIC

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 2010Ramiciotti Equipment grant. Chris Cowell, Cheryl Jones, Geraldine O’Neill, Kathy North, Jennifer Byrne, John Christodoulou, Rachael Murray, Sandra Cooper, Laurence Cantrill equipment grant towards the Correlative Light and Electron Microscopy Suite. 2010-11 Australian Centre for HIV and Hepatitis C Research (ACH2) grant. A Cunningham, M Kim, W Jackson, W Dyer, C Jones (CI-E). Can HIV lipopeptide induce Th17 responses.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Leon Heron, FRCPA,
    13. Scientific Advisory Boards:

    1. Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Sanofi Pasteur

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis; Sanofi Pasteur; Baxter

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Mary McCaskill, FACEM,
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Kristine Macartney, MD,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Salary from National Centre for Immunisation Research and Surveillance (see below).

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) Australian Government Department of Health and Ageing, Funding provided to the National Centre for Immunisation Research and Surveillance

    Research Support, Academic Entities:

    1. Deputy Director, The National Centre for Immunisation Research and Surveillance, Westmead Children’s Hospital, Westmead, NSW, 2145, Australia (Funding provided by both Commonwealth and State Governments)

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Elizabeth J. Elliott, MD and
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council, Australia. Grant number 633028. Chief Invesigator A; 1 year 2009-2010

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Robert Booy, MD
    17. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. I have received financial support from CSL, Sanofi, GSK, Roche, Novartis and Wyeth, to conduct research and present at scientific meetings. Any funding received is directed to an NCIRS research account at The Children’s Hospital at Westmead and is not personally accepted by me.

    Editorial Boards:

    1. Editorial advisory board member: Journal of Pediatric Infectious Diseases, Journal of Infection and Public Health

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Head of Clinical Research, National Centre for Immunisation Research and Surveillance of Vaccine- Preventable Disease, The Children’s Hospital at Westmead, Cnr Hawkesbury Rd and Hainsworth St, Locked Bag 4001, Westmead, NSW 2145, Australia.

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NSW State Department of Health and the National Health and Medical Research Council (NHMRC) H1N1 Grant no: 633028, 2009 to conduct the research.

    Research Support, Academic Entities:

    1. Professor of Pediatrics, The University of Sydney, NSW, Australia

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (G.K., T.S., L.H., K.M., R.B.), Sydney; The Discipline of Paediatrics and Child Health (G.K., Y.Z., R.C.D., C.J., L.H., K.M., E.J.E., R.B.), The University of Sydney, Sydney; The Australian Paediatric Surveillance Unit (Y.Z., E.J.E.), Sydney; Murdoch Children's Research Institute (J.B., J.R.), and Immunisation Service, Department of General Medicine, Royal Children's Hospital, Melbourne; Department of Paediatrics (J.B.), Monash University, Melbourne; Vaccinology and Immunology Research Trials Unit (H.M.), Women's and Children's Hospital, Adelaide, South Australia; School of Paediatrics and Reproductive Health (H.M., M.G.), University of Adelaide, South Australia; School of Paediatrics and Child Health (P.C.R.), University of Western Australia, Perth; Sydney Children's Hospital (T.S.), Randwick; Respiratory Medicine (B.W.), John Hunter Children's Hospital, New South Wales; Department of Emergency Medicine (M.M.), The Children's Hospital at Westmead, Sydney; and The Sydney Institute for Emerging Infections and Biosecurity (SEIB) (C.J., L.H., K.M., E.J.E., R.B.), Sydney Medical School, The University of Sydney, Sydney, Australia.
  1. Correspondence & reprint requests to Dr. Booy: robertb2{at}chw.edu.au
View Full Text

Article usage

Article usage: September 2012 to February 2023

AbstractFullPdfSource
Sep 2012217317Highwire
Oct 201214486666Highwire
Nov 20121912021Highwire
Dec 20121362119Highwire
Jan 20131721616Highwire
Feb 201373159Highwire
Mar 20136066Highwire
Apr 20134056Highwire
May 20135463Highwire
Jun 20134213Highwire
Jul 20133373Highwire
Aug 20133314Highwire
Sep 20133667Highwire
Oct 20132882Highwire
Nov 20131932Highwire
Dec 20133163Highwire
Jan 20143965Highwire
Feb 20143974Highwire
Mar 20141965Highwire
Apr 20142387Highwire
May 20142474Highwire
Jun 20142352Highwire
Jul 20143764Highwire
Aug 20141284Highwire
Sep 201423104Highwire
Oct 20144012Highwire
Nov 20144111Highwire
Dec 20141303Highwire
Jan 20152900Highwire
Jan 20150219pmc
Feb 20152022Highwire
Feb 20150145pmc
Mar 20153300Highwire
Mar 201502516pmc
Apr 20151500Highwire
Apr 20150235pmc
May 20151912Highwire
May 2015064pmc
Jun 20151000Highwire
Jun 2015064pmc
Jul 2015800Highwire
Jul 2015071pmc
Aug 20151700Highwire
Aug 20150125pmc
Sep 20152600Highwire
Sep 20150104pmc
Oct 20151901Highwire
Oct 20150130pmc
Nov 20152400Highwire
Nov 20150257pmc
Dec 20152300Highwire
Dec 20150105pmc
Jan 20163111Highwire
Jan 20160187pmc
Feb 20162601Highwire
Feb 201602212pmc
Mar 20163133Highwire
Mar 201602210pmc
Apr 20161520Highwire
Apr 20160133pmc
May 2016900Highwire
May 201601512pmc
Jun 20161814Highwire
Jun 20160113pmc
Jul 20162420Highwire
Jul 20160147pmc
Aug 20162300Highwire
Aug 20160164pmc
Sep 20161500Highwire
Sep 2016094pmc
Oct 20161711Highwire
Oct 20160113pmc
Nov 20161611Highwire
Nov 2016097pmc
Dec 20161601Highwire
Dec 20160155pmc
Jan 20172001Highwire
Jan 20170158pmc
Feb 20171700Highwire
Feb 20170118pmc
Mar 20172201Highwire
Mar 20170157pmc
Apr 20171600Highwire
Apr 201761517pmc
May 20172000Highwire
May 201752325pmc
Jun 2017801Highwire
Jun 2017255pmc
Jul 20171100Highwire
Jul 201731619pmc
Aug 201722400Highwire
Aug 201732124pmc
Sep 20171100Highwire
Sep 201731721pmc
Oct 20171000Highwire
Oct 201762024pmc
Nov 2017800Highwire
Nov 201792123pmc
Dec 20172500Highwire
Jan 20181700Highwire
Feb 2018900Highwire
Mar 20182410Highwire
Apr 20181800Highwire
Apr 2018399pmc
May 20181600Highwire
Jun 20182300Highwire
Jun 201851619pmc
Jul 20182400Highwire
Aug 20182320Highwire
Aug 201831822pmc
Sep 20181500Highwire
Oct 20181800Highwire
Nov 20182500Highwire
Dec 20181700Highwire
Jan 20192200Highwire
Feb 20191800Highwire
Mar 20192600Highwire
Apr 20191300Highwire
May 20192700Highwire
Jun 20191400Highwire
Jul 20191901Highwire
Aug 2019611Highwire
Sep 20191200Highwire
Oct 20192110Highwire
Nov 20192400Highwire
Dec 20191331Highwire
Jan 20203424Highwire
Feb 20201600Highwire
Mar 20202800Highwire
Apr 2020400Highwire
May 20201810Highwire
Jun 20201500Highwire
Jul 20201800Highwire
Aug 20201043Highwire
Sep 20204600Highwire
Oct 20204100Highwire
Nov 20204720Highwire
Dec 20204011Highwire
Jan 20212802Highwire
Feb 20212921Highwire
Mar 20214801Highwire
Apr 20212600Highwire
May 20215301Highwire
Jun 2021730Highwire
Jul 20212011Highwire
Aug 20212411Highwire
Sep 20212701Highwire
Oct 20214000Highwire
Nov 20212200Highwire
Dec 20211412Highwire
Jan 20222702Highwire
Feb 20224017Highwire
Mar 20224014Highwire
Apr 20224200Highwire
May 20225300Highwire
Jun 20223600Highwire
Jul 20221701Highwire
Aug 20224900Highwire
Sep 20222910Highwire
Oct 20221800Highwire
Nov 20223211Highwire
Dec 20225500Highwire
Jan 20233112Highwire
Feb 20232810Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me

Recommended articles